Trial intelligence / Profile preview

Celecoxib for pain control after paediatric tonsillectomy

ACTRN12621001390875Phase 3Recruiting

Sponsor
Gosford Hospital
Start
Feb 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative pain comparing Celecoxib arm with Placebo arm (2 arms). Primary endpoint: Average pain on postoperative day at Day 14. Started Feb 2022; status: recruiting.

02

Drugs

celecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12621001390875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12621001390875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call